MedTrace Logo

Visumax Femtolasik Versus Moria M2 Microkeratome in Myopia

NCT03193411 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2017-06-20

No results posted yet for this study

Summary

this is an interventional prospective clinical study which was conducted to evaluate the efficacy, safety, predictability, ocular aberrations, and flap thickness predictability of Visumax femtosecond laser (FSL) compared to Moria M2 microkeratome (MK) in mild to moderate myopia.

Conditions

  • Lasik in Myopia

Interventions

DEVICE

Visumax femtosecond laser

DEVICE

Moria M2 microkeratome (MK)

Sponsors & Collaborators

  • Dar Al Shifa Hospital

    lead OTHER

Principal Investigators

  • Magda Torky · daralshifa hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2014-05-29
Completion
2014-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03193411 on ClinicalTrials.gov